<scp>RBBP4</scp>: A novel diagnostic and prognostic biomarker for non‐small‐cell lung cancer correlated with autophagic cell death
In NSCLC, RBBP4 upregulation correlates with poor prognosis and altered immunity. Its knockdown induces autophagic cell death in NSCLC cells. These results indicate RBBP4 as a potential NSCLC diagnostic marker and its autophagy modulation as a prospective therapeutic target.
Authors
- Yajing Zhan (ORCID: https://orcid.org/0009-0009-5014-6351)
- Xiyang Su (ORCID: https://orcid.org/0000-0001-9412-997X)
- Zebin Zhang (ORCID: https://orcid.org/0000-0002-9828-4245)
- Ankang Yin (ORCID: https://orcid.org/0000-0002-1933-601X)
- Wei Chen (ORCID: https://orcid.org/0000-0003-2551-4916)
- Juan Wang (ORCID: https://orcid.org/0000-0001-9745-6087)
- Wei Wang (ORCID: https://orcid.org/0000-0002-8511-1775)
- Zhiqian Zhang (ORCID: https://orcid.org/0000-0003-0289-2885)
- Nan Tang (ORCID: https://orcid.org/0000-0002-4771-5324)
- Yi Chen (ORCID: https://orcid.org/0000-0001-6167-8032)
Institutions
- Zhejiang Chinese Medical University (CN)
- Tongde Hospital of Zhejiang Province (CN)
- Zhejiang Provincial People's Hospital (CN)
- Shaoxing People's Hospital (CN)
- Hangzhou Medical College (CN)
- People's Hospital of Wangcheng District Changsha
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cam4.70090
- Citations
- 5
- Primary Topic
- Autophagy in Disease and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- National Natural Science Foundation of China